Top Upgrades

  • Raymond James upgraded American Airlines Group Inc AAL from Market Perform to Outperform. American Airlines shares gained 0.65 percent to $44.67 in pre-market trading.
  • Analysts at Morgan Stanley upgraded Pfizer Inc. PFE from Equal-Weight to Overweight. Pfizer shares gained 0.96 percent to $35.79 in pre-market trading.
  • Credit Suisse upgraded Progressive Corp PGR from Underperform to Neutral. Progressive shares rose 2.85 percent to close at $47.63 on Tuesday.
  • Susquehanna upgraded Hibbett Sports, Inc. HIBB from Neutral to Positive. Hibbett shares closed at $13.15 on Tuesday.
  • BMO Capital upgraded Post Holdings Inc POST from Market Perform to Outperform. Post Holdings shares rose 0.61 percent to close at $86.36 on Tuesday.
  • Argus upgraded Bioverativ Inc BIVV from Hold to Buy. Bioverativ shares rose 0.50 percent to close at $56.39 on Tuesday.
  • Analysts at JP Morgan upgraded Dover Corp DOV from Neutral to Overweight. Dover shares rose 1.01 percent to close at $90.96 on Tuesday.
  • Morgan Stanley upgraded Arista Networks Inc ANET from Equal-Weight to Overweight. Arista Networks shares fell 0.53 percent to close at $181.72 on Tuesday.
  • Analysts at Raymond James upgraded Southwest Airlines Co LUV from Market Perform to Outperform. Southwest shares rose 1.79 percent to $54.50 in pre-market trading.


Top Downgrades

  • Raymond James downgraded United Continental Holdings Inc UAL from Outperform to Market Perform. United Continental shares declined 0.31 percent to $57.36 in pre-market trading.
  • Cowen & Co. downgraded L Brands Inc LB from Outperform to Market Perform. L Brands shares slipped 1.88 percent to close at $39.23 on Tuesday.
  • Wedbush downgraded Signature Bank SBNY from Outperform to Neutral. Signature Bank shares gained 0.18 percent to close at $120.15 on Tuesday.
  • Jefferies downgraded TransDigm Group Incorporated TDG from Buy to Hold. TransDigm shares gained 0.21 percent to close at $265.20 on Tuesday.
  • Analysts at JP Morgan downgraded 3M Co MMM from Neutral to Underweight. 3M shares declined 1.43 percent to $210.50 in pre-market trading.
  • Morgan Stanley downgraded Allergan plc AGN from Overweight to Equal-Weight. Allergan shares declined 1.16 percent to $212.50 in pre-market trading.
  • Analysts at Raymond James downgraded Tintri Inc TNTR from Outperform to Underperform. Tintri shares dropped 10.95 percent to close at $3.66 on Tuesday.
  • JP Morgan downgraded Ingersoll-Rand PLC IR from Overweight to Neutral. Ingersoll-Rand shares slipped 0.06 percent to close at $90.46 on Tuesday.


Top Initiations

  • Analysts at Credit Suisse initiated coverage on Vistra Energy Corp VST with an Outperform rating. The price target for Vistra Energy is set to $20. Vistra Energy shares closed at $17.88 on Tuesday.
  • Analysts at Barclays initiated coverage of Ralph Lauren Corp RL with an Underweight rating. The price target for Ralph Lauren is set to $84. Ralph Lauren shares closed at $91.03 on Tuesday.
  • Argus initiated coverage on Intuit Inc. INTU with a Buy rating. The price target for Intuit is set to $165. Intuit shares closed at $145.34 on Tuesday.
  • Jefferies initiated coverage on Epizyme Inc EPZM with a Buy rating. The price target for Epizyme is set to $23. Epizyme shares closed at $19.25 on Tuesday.
  • Barclays initiated coverage on PVH Corp PVH with an Overweight rating. The price target for PVH is set to $147. PVH shares closed at $127.47 on Tuesday.
  • Buckingham initiated coverage on Electronic Arts Inc. EA with a Buy rating. Electronic Arts shares closed at $120.21 on Tuesday.
  • Analysts at Cantor Fitzgerald initiated coverage on CymaBay Therapeutics Inc CBAY with an Overweight rating. The price target for CymaBay Therapeutics is set to $16. CymaBay Therapeutics shares closed at $6.99 on Tuesday.
  • Analysts at SunTrust Robinson Humphrey initiated coverage on Biogen Inc BIIB with a Buy rating. The price target for Biogen is set to $360. Biogen closed at $317.93 on Tuesday.
  • Analysts at Barclays initiated coverage on Coach Inc COH with an Equal-Weight rating. The price target for Coach is set to $45. Coach shares closed at $40.35 on Tuesday.
  • KeyBanc initiated coverage of Evolent Health Inc EVH with an Overweight rating. The price target for Evolent Health is set to $23. Evolent Health shares closed at $15.65 on Tuesday.
Market News and Data brought to you by Benzinga APIs
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!